Oral Medication for Agitation of Psychiatric Origin: A Scoping Review of Randomized Controlled Trials.
The Journal of emergency medicine · 2017-07-21 · Scoping review
Abstract
BACKGROUND: Understanding more about the efficacy and safety of oral second-generation antipsychotic medications in reducing the symptoms of acute agitation could improve the treatment of psychiatric emergencies. OBJECTIVE: The objective of this scoping review was to examine the evidence base underlying expert consensus panel recommendations for the use of oral second-generation antipsychotics to treat acute agitation in mentally ill patients. METHODS: The Cochrane Schizophrenia Group's Study-Based Register was searched for randomized controlled trials comparing oral second-generation antipsychotics, benzodiazepines, or first-generation antipsychotics with or without adjunctive benzodiazepines, irrespective of route of administration of the drug being compared. Six articles were included in the final review. RESULTS: Two oral second-generation antipsychotic medications were studied across the six included trials. While the studies had relatively small sample sizes, oral second-generation antipsychotics were similarly effective to intramuscular first-generation antipsychotics in treating symptoms of acute agitation and had similar side-effect profiles. CONCLUSIONS: This scoping review identified six randomized trials investigating the use of oral second-generation antipsychotic medications in the reduction of acute agitation among patients experiencing psychiatric emergencies. Further research will be necessary to make clinical recommendations due to the overall dearth of randomized trials, as well as the small sample sizes of the included studies.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antipsychotics · Other benzodiazepines & Z-drugs · Sedatives & anxiolytics
Related articles
- Agitation management strategies for older adults in the emergency department or with emergency medical services: A scoping review. (Am J Emerg Med, 2025)
- Treatment of Agitation With Lorazepam in Clinical Practice: A Systematic Review. (Front Psychiatry, 2021)
- Evidence for using PRN pharmacotherapy to treat undifferentiated acute agitation or aggression. (Ann Clin Psychiatry, 2019)
- Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department. (Acad Emerg Med, 2021)
- Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study. (Am J Emerg Med, 2021)
- Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial. (J Formos Med Assoc, 2015)